Physician profile
Emily L Wright
NPI 1255943452
$839.41
in general payments reported to CMS, 2019-2025
15 companies · $512 in 2025
The $512 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $205 · 2024: $123 · 2025: $512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $757 · Education: $82.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $756.73 |
| Education | $82.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $204.55 | 2023 | |
| Recordati_rare_diseases_inc. | $103.57 | 2025 | Isturisa |
| Organon LLC | $86.82 | 2024 | |
| Caris Mpi, INC. | $73.34 | 2025 | Mi Cancer Seek |
| Abbvie INC. | $68.56 | 2025 | |
| Daiichi Sankyo INC. | $59.73 | 2025 | Enhertu |
| Novartis Pharmaceuticals Corporation | $56.62 | 2025 | |
| Merck Sharp & Dohme LLC | $39.25 | 2024-2025 | Keytruda |
| Astrazeneca Pharmaceuticals LP | $33.50 | 2025 | Enhertu |
| Dendreon Pharmaceuticals LLC | $20.32 | 2025 | Provenge |
| Genentech USA, INC. | $19.38 | 2024 | Tecentriq, Herceptin, Tecentriq Hybreza |
| Eisai INC. | $19.16 | 2025 | |
| Immunocore Limited | $18.88 | 2025 | Kimmtrak |
| Immunitybio, INC. | $18.55 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $17.18 | 2025 | Dysport |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.